PreveCeutical Medical Statistics
Total Valuation
PRVCF has a market cap or net worth of 8.78 million. The enterprise value is 12.11 million.
| Market Cap | 8.78M |
| Enterprise Value | 12.11M |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 598.19M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.42% |
| Shares Change (QoQ) | +1.84% |
| Owned by Insiders (%) | 24.74% |
| Owned by Institutions (%) | n/a |
| Float | 450.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.41 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.44 |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.66 |
| Interest Coverage | -8.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -368.89% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 36.68% |
| Weighted Average Cost of Capital (WACC) | 4.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.71% in the last 52 weeks. The beta is -0.03, so PRVCF's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -15.71% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 49.25 |
| Average Volume (20 Days) | 23,526 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.93M |
| Pretax Income | -2.24M |
| Net Income | -2.24M |
| EBITDA | -1.92M |
| EBIT | -1.93M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 74,433 in cash and 3.30 million in debt, with a net cash position of -3.23 million.
| Cash & Cash Equivalents | 74,433 |
| Total Debt | 3.30M |
| Net Cash | -3.23M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.31M |
| Book Value Per Share | -0.01 |
| Working Capital | -5.38M |
Cash Flow
In the last 12 months, operating cash flow was -898,421 and capital expenditures -2,643, giving a free cash flow of -901,064.
| Operating Cash Flow | -898,421 |
| Capital Expenditures | -2,643 |
| Free Cash Flow | -901,064 |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRVCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.42% |
| Shareholder Yield | -3.42% |
| Earnings Yield | -25.51% |
| FCF Yield | -10.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |